Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 43

Results For "2022"

1455 News Found

Alembic Q4 FY23 consolidated PAT up at Rs. 48.25 Cr
News | May 13, 2023

Alembic Q4 FY23 consolidated PAT up at Rs. 48.25 Cr

Alembic has reported total income of Rs. 39.15 crores during the period ended March 31, 2023


Cipla reports Q4 FY 23 consolidated PAT at Rs. 525.65 Cr
News | May 13, 2023

Cipla reports Q4 FY 23 consolidated PAT at Rs. 525.65 Cr

Cipla has reported total income of Rs. 5873.93 crores during the period ended March 31, 2023


Bliss GVS Pharma Q4 FY2023 consolidated PAT drops at Rs. 3.34 Cr
News | May 12, 2023

Bliss GVS Pharma Q4 FY2023 consolidated PAT drops at Rs. 3.34 Cr

The company has reported total income of Rs. 187.75 crores during the period ended March 31, 2023


Orchid Pharma Q4 FY23 consolidated PAT up at Rs. 59.13 Cr
News | May 11, 2023

Orchid Pharma Q4 FY23 consolidated PAT up at Rs. 59.13 Cr

The company has reported total income of Rs. 211.62 crores during the period ended March 31, 2023


Lupin posts Q4FY23 consolidated PAT up at Rs. 235.96 Cr
News | May 10, 2023

Lupin posts Q4FY23 consolidated PAT up at Rs. 235.96 Cr

The company has reported total income of Rs. 4467.35 crores during the quarter ended March 31, 2023


IOL Chemicals and Pharmaceuticals receives CEP for Paracetamol to export in European market
Drug Approval | May 09, 2023

IOL Chemicals and Pharmaceuticals receives CEP for Paracetamol to export in European market

The certification issued by the EDQM verifies the compliance of pharmaceutical substances


Tatva Chintan Pharma Chem posts Q4FY23 consolidated PAT at Rs. 16.95 Cr
News | May 07, 2023

Tatva Chintan Pharma Chem posts Q4FY23 consolidated PAT at Rs. 16.95 Cr

Tatva Chintan Pharma Chem has reported total income of Rs. 125.35 crores during the period ended March 31, 2023


Alembic Pharmaceuticals posts Q4FY2023 consolidated PAT at Rs. 152.60 Cr
News | May 07, 2023

Alembic Pharmaceuticals posts Q4FY2023 consolidated PAT at Rs. 152.60 Cr

The company has reported total income of Rs. 1407.34 crores during the period ended March 31, 2023


Ajanta pharma posts Q4FY23 consolidated PAT at Rs. 122.25 Cr
News | May 06, 2023

Ajanta pharma posts Q4FY23 consolidated PAT at Rs. 122.25 Cr

The company has reported total income of Rs. 918.67 crores during the period ended March 31, 2023


Mandaviya reviews organ donation policy
Policy | May 04, 2023

Mandaviya reviews organ donation policy

Organ Transplants triple across the country; rise from 5000 (2013) to more than 15000 in 2022